Drug
Crisaborole clinical trials
Also written Eucrisa and AN2728.
- studies test it
- 40
- open now
- 6
- in phase 3
- 8
- first study started
- 2007
Keep track of what changes. Save the crisaborole studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
- Eucrisa
- 12
Development codes
Studies by the year they started
40 studies that test it; most in 2019 (6)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 2 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 5 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 5
- Phase 2
- 15
- Phase 3
- 8
- Phase 4
- 11
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 21 · Other 19
Pfizer (21) · Noura Abdelmoneim Mohammed Elseessy (1) · Sheffield Teaching Hospitals NHS Foundation Trust (1) · Johns Hopkins University (1) · University of Colorado, Denver (1) · University of California, Irvine (1) · University of Rochester (1) · Ann & Robert H Lurie Children's Hospital of Chicago (1)
Often tested with
Tested in the same studies.
Tacrolimus (3) · Fluticasone (1) · Betamethasone Valerate (1) · Betamethasone (1) · PF-07038124 (1) · AN-2898 (1) · Triamcinolone (1) · Fluorouracil (1)
Studies
Open first, then newest update. How each study uses crisaborole is read from its arms, and is right about nine times in ten.
Testing it · 40
- Efficacy of Crisaborole 2% Ointment Versus Tacrolimus 0.1% Ointment in the Treatment of Intertriginous and/or Anogenital Psoriasis: A Prospective Randomized Controlled Study.Not yet recruitingPhase 3Cairo UniversityNCT07892339Written as Crisaborole 2% topical ointment
- Utilization of a Microdevice for Psoriasis and Atopic DermatitisNot yet recruitingPhase 4University of California, San FranciscoNCT07352566Written as Crisaborole
- Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic EczemaNot yet recruitingPhase 4Jinnah Postgraduate Medical CentreNCT07438509Written as Crisaborole 2% Cream
- Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic DermatitisNot yet recruitingPhase 4Hayat Abad Medical Complex, PeshawarNCT07437534Written as Crisaborole 2% Topical Application Ointment [EUCRISA
- Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic DermatitisNot yet recruitingPhase 3Shalamar Institute of Health SciencesNCT07162896Written as Crisaborole 2%
- Crisaborole Ointment for Skin Toxicity Induced by CetuximabRecruitingPhase 2Sun Yat-sen UniversityNCT06118047Written as Crisaborole Ointment
- Crisaborole vs Fluticasone Propionate in Mild to Moderate Atopic DermatitisCompletedNot applicableNoura Abdelmoneim Mohammed ElseessyNCT07537751Written as Crisaborole 2% topical ointment
- Skin bioMARkers for Atopic Eczema Therapy EvaluationCompletedPhase 2Sheffield Teaching Hospitals NHS Foundation TrustNCT04194814Written as crisaborole (2%) ointment
- Improvement In Scratch Behavior And Sleep In Patients With Atopic DermatitisTerminatedPhase 4Boston UniversityNCT05200403Written as Crisaborole 2%
- Topical Crisaborole in Patients with Alopecia AreataWithdrawnPhase 2Tufts Medical CenterNCT04299503Written as Crisaborole Topical Ointment
- Steroid-reducing Effects of CrisaboroleCompletedPhase 4Johns Hopkins UniversityNCT03832010Written as Crisaborole
- Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in VitiligoCompletedPhase 2University of Colorado, DenverNCT05298033Written as Crisaborole 2 % Topical Ointment
- Characterizing Skin Microbiome Change in Atopic DermatitisCompletedEarly Phase 1University of California, IrvineNCT04800185Written as Crisaborole 2% Top Oint
- A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic DermatitisCompletedPhase 3PfizerNCT04040192Written as Crisaborole 2%
- ASPIRE: PROs & Caregiver Burden in Children With Atopic DermatitisCompletedPhase 3University of RochesterNCT03645057Written as Crisaborole
- Response of Children With Atopic Dermatitis (Eczema) to EucrisaCompletedPhase 4Ann & Robert H Lurie Children's Hospital of ChicagoNCT04023084Written as Crisaborole
- Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic DermatitisCompletedPhase 3PfizerNCT04360187Written as Crisaborole Ointment
- Study Evaluating Efficacy and Safety of Crisaborole in Adults With Stasis DermatitisCompletedPhase 2PfizerNCT04091087Written as crisaborole ointment
- A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate ADTerminatedPhase 4PfizerNCT03539601Written as Crisaborole ointment, 2%
- A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic DermatitisCompletedPhase 4University of Alabama at BirminghamNCT03567980Written as Crisaborole
See all 40 studies that test crisaborole →
Given in every arm · 1 — crisaborole is usual care beside what is tested
As the comparator · 2 — what is tested is compared with crisaborole
- A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 WeeksNot yet recruitingNot applicableFoundation University IslamabadNCT07519174Written as Crisaborole 2% Top Oint
- Comparison of JW-100 and EUCRISA for the Treatment of Atopic DermatitisWithdrawnPhase 3Applied Biology, Inc.NCT05016284Written as Eucrisa
Codes
What other systems call crisaborole · ClinicalTrials.gg INT005480
- MeSH (NLM) C543085crisaboroleConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) Q2R47HGR7PCRISABOROLEConfirmed FDA, NLM, Wikidata
- RxNorm 1865953Confirmed FDA, Wikidata
- Wikidata Q21098894crisaboroleConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C174863CrisaboroleOne source FDA
- DrugBank DB05219One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C543085 | crisaborole | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | Q2R47HGR7P | CRISABOROLE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1865953 | — | Confirmed FDA, Wikidata |
| Wikidata | Q21098894 | crisaborole | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C174863 | Crisaborole | One source FDA |
| DrugBank | DB05219 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.